AATD
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study to Assess the Safety, PK and PD of INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency (NCT03815396) | Inhibrx Biosciences, Inc | 2019-07-19 |
| Genomic Research in Alpha-1 Antitrypsin Deficiency (NCT01832220) | University of Pittsburgh | 2013-05-01 |
| Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs (NCT01851642) | University of Florida | 2007-08-09 |
Track AATD automatically
Every clearance here is in the API, with alerts when new ones post.